Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: Serbia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20151
20161
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring1
Esperion Therapeutics, Inc.1
Genfit1
GlaxoSmithKline1
Heidelberg University1
Menarini International Operations Luxembourg SA1
NYU Langone Health1
Novartis Pharmaceuticals1
Takeda1
United Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases10
Hypertension4
Coronary Artery Disease2
Heart Diseases2
Heart Failure2
Vascular Diseases2
Acute Coronary Syndrome1
Arthritis1
Atherosclerosis1
Atrial Fibrillation1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.